Atherosclerotic-like process in aortic stenosis: Activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration

被引:69
作者
Breyne, Joke [1 ]
Juthier, Francis [1 ,2 ]
Corseaux, Delphine [1 ]
Marechaux, Sylvestre [1 ,2 ]
Zawadzki, Christophe [1 ,2 ,3 ]
Jeanpierre, Emmanuelle [1 ,2 ,3 ]
Ung, Alexandre [1 ,2 ]
Ennezat, Pierre-Vladimir [1 ,2 ]
Susen, Sophie [1 ,2 ]
Van Belle, Eric [1 ,2 ]
Le Marec, Herve [3 ]
Vincentelli, Andre [1 ,2 ]
Le Tourneau, Thierry [1 ,3 ]
Jude, Brigitte [1 ,2 ]
机构
[1] Univ Lille Nord France, IFR 114, EA 2693, F-59000 Lille, France
[2] CHU Lille, F-59045 Lille, France
[3] Univ Nantes, CHU Nantes, INSERM, Inst Thorax,UMR915, F-44007 Nantes, France
关键词
Atherosclerosis; Coagulation; Stenosis; Aortic valve disease; Tissue factor; CONVERTING ENZYME-INHIBITORS; FACTOR EXPRESSION; VALVE CALCIFICATION; EARLY LESION; PROGRESSION; INFLAMMATION; ASSOCIATION; PLAQUES; DISEASE; MINERALIZATION;
D O I
10.1016/j.atherosclerosis.2010.07.047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We recently demonstrated in an experimental model the expression of tissue factor (TF) in aortic valves. Thrombin, generated at the end of the TF-initiated coagulation cascade, has been shown to cleave the anti-calcific osteopontin (OSP) liberating the pro-inflammatory OSP N-half. Objectives: We hypothesized that TF might play an important role in calcific aortic valve stenosis (AS) through thrombin generation and hence evaluated the valvular expression of TF and its inhibitor (TF pathway inhibitor), alpha-thrombin, OSP and its thrombin-cleaved form (OSP N-half). Methods: Calcified aortic valves were obtained from patients undergoing valve replacement. Protein expression was evaluated by immunostaining and measured using ELISA kits. Transcripts were analyzed by RT-PCR. Results: We included 52 patients (31 men; age 70 +/- 10 years; aortic valve area index 0.35 +/- 0.13cm(2)/m(2)). Immunohistochemistry revealed that TF, OSP and alpha-thrombin expressions were associated with calcifications at the aortic side of the leaflets. There was an overexpression in calcified regions as compared to non-calcified zones of TF (733.3 +/- 70.5 pg/mg vs. 429.4 +/- 73.2 pg/mg; p < 0.0001), OSP (88.9 +/- 12.7 ng/mg vs. 15.0 +/- 3.3 ng/mg; p < 0.0001) and OSP N-half (0.41 +/- 0.06 pmol/mg vs. 0.056 +/- 0.011 pmol/mg; p < 0.0001). Additionally, both TF and alpha-thrombin expressions were associated with OSP N-half (r = 0.52; p < 0.0001 and r = 0.33; p = 0.019, respectively). Conclusions: Aortic leaflet TF and alpha-thrombin expressions and their association with the thrombin-cleaved form of OSP, are a new and important feature of AS. We hypothesize that TF may be involved in the mineralization process of aortic valves by enhancing the generation of the pro-inflammatory OSP N-half through thrombin induction. This pathway deserves further studies to address its implication in the aortic valve calcification process. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 44 条
  • [1] Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering
    Baetta, R
    Camera, M
    Comparato, C
    Altana, C
    Ezekowitz, MD
    Tremoli, E
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) : 692 - 698
  • [2] Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications
    Bajaj, M. S.
    Ghosh, M.
    Bajaj, S. P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1493 - 1499
  • [3] Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community
    Bellamy, MF
    Pellikka, PA
    Klarich, KW
    Tajik, AJ
    Enriquez-Sarano, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) : 1723 - 1730
  • [4] INITIATION AND PROGRESSION OF MINERALIZATION OF BONE NODULES FORMED INVITRO - THE ROLE OF ALKALINE-PHOSPHATASE AND ORGANIC PHOSPHATE
    BELLOWS, CG
    AUBIN, JE
    HEERSCHE, JNM
    [J]. BONE AND MINERAL, 1991, 14 (01): : 27 - 40
  • [5] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [6] Role of tissue factor in embryonic blood vessel development
    Carmeliet, P
    Mackman, N
    Moons, L
    Luther, T
    Gressens, P
    VanVlaenderen, I
    Demunck, H
    Kasper, M
    Breier, G
    Evrard, P
    Muller, M
    Risau, W
    Edgington, T
    Collen, D
    [J]. NATURE, 1996, 383 (6595) : 73 - 75
  • [7] Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial
    Chan, Kwan Leung
    Teo, Koon
    Dumesnil, Jean G.
    Ni, Andy
    Tam, James
    [J]. CIRCULATION, 2010, 121 (02) : 306 - U247
  • [8] Vastatins inhibit tissue factor in cultured human macrophages - A novel mechanism of protection against atherothrombosis
    Colli, S
    Eligini, S
    Lalli, M
    Camera, M
    Paoletti, R
    Tremoli, E
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) : 265 - 272
  • [9] A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis
    Cowell, SJ
    Newby, DE
    Prescott, RJ
    Bloomfield, P
    Reid, J
    Northridge, DB
    Boon, NA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) : 2389 - 2397
  • [10] Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
    Denhardt, DT
    Noda, M
    O'Regan, AW
    Pavlin, D
    Berman, JS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) : 1055 - 1061